• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码RNA H19作为癌症生物标志物在人类癌症检测与诊断中的潜在作用:基于1585名受试者的汇总分析

Potential Role of lncRNA H19 as a Cancer Biomarker in Human Cancers Detection and Diagnosis: A Pooled Analysis Based on 1585 Subjects.

作者信息

Liu Yuhan, He Anbang, Liu Baoer, Huang Zhengxian, Mei Hongbing

机构信息

Department of Urology, Shenzhen Second People's Hospital, the First Affiliated Hospital of Shenzhen University, Shenzhen 518000, China.

Department of Urology, Peking University First Hospital, The Institute of Urology, Peking University, National Urological Cancer Centre, Beijing 100034, China.

出版信息

Biomed Res Int. 2019 Mar 19;2019:9056458. doi: 10.1155/2019/9056458. eCollection 2019.

DOI:10.1155/2019/9056458
PMID:31016202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6444267/
Abstract

Long noncoding RNAs (lncRNAs) have been reported to serve as diagnostic and prognostic biomarkers of cancers, which play vital roles in tumorigenesis and tumor progression. Several studies have been performed to explore diagnostic value of lncRNA H19 in cancer detection and diagnosis. However, there are still inconsistent results in diagnostic accuracy and reliability in individual studies. Therefore, the present study was performed to summarize the overall diagnostic performance of lncRNA H19 in cancer detection and diagnosis. A total of eight studies with 770 cases and 815 controls were included in this pooled analysis. The pooled diagnostic results were as follows: sensitivity, 0.69 (95%CI=0.62-0.76), specificity, 0.79 (95% CI=0.70-0.86), positive likelihood ratio (PLR), 3.31 (95%CI=2.29-4.78), negative likelihood (NLR), 0.39 (95%CI=0.31-0.49), diagnostic odds ratio (DOR), 8.53 (95%CI=4.99-14.60), and area under the curve (AUC), 0.79 (95%CI=0.76-0.83). Deeks' funnel plot asymmetry test (P=0.13) suggested no potential publication bias. Our results indicated that lncRNA H19 had a relatively moderate accuracy in cancer detection and diagnosis. Further comprehensive prospective studies with large sample sizes are urgently required to validate our findings.

摘要

据报道,长链非编码RNA(lncRNAs)可作为癌症的诊断和预后生物标志物,在肿瘤发生和肿瘤进展中发挥重要作用。已经进行了多项研究来探索lncRNA H19在癌症检测和诊断中的诊断价值。然而,个别研究在诊断准确性和可靠性方面仍存在不一致的结果。因此,本研究旨在总结lncRNA H19在癌症检测和诊断中的总体诊断性能。本荟萃分析共纳入八项研究,涉及770例病例和815例对照。汇总诊断结果如下:敏感性为0.69(95%CI=0.62-0.76),特异性为0.79(95%CI=0.70-0.86),阳性似然比(PLR)为3.31(95%CI=2.29-4.78),阴性似然比(NLR)为0.39(95%CI=0.31-0.49),诊断比值比(DOR)为8.53(95%CI=4.99-14.60),曲线下面积(AUC)为0.79(95%CI=0.76-0.83)。Deeks漏斗图不对称检验(P=0.13)表明无潜在发表偏倚。我们的结果表明,lncRNA H19在癌症检测和诊断中具有相对中等的准确性。迫切需要进一步开展大样本量的全面前瞻性研究来验证我们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/c398beb11b4f/BMRI2019-9056458.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/99037fd13c0d/BMRI2019-9056458.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/2eaeea8ea9e5/BMRI2019-9056458.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/b460635238e2/BMRI2019-9056458.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/7a3e0feb0604/BMRI2019-9056458.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/cbb3d3ea16c8/BMRI2019-9056458.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/888af505ab5b/BMRI2019-9056458.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/07977baba64c/BMRI2019-9056458.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/bb4c0d10a91d/BMRI2019-9056458.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/c398beb11b4f/BMRI2019-9056458.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/99037fd13c0d/BMRI2019-9056458.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/2eaeea8ea9e5/BMRI2019-9056458.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/b460635238e2/BMRI2019-9056458.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/7a3e0feb0604/BMRI2019-9056458.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/cbb3d3ea16c8/BMRI2019-9056458.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/888af505ab5b/BMRI2019-9056458.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/07977baba64c/BMRI2019-9056458.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/bb4c0d10a91d/BMRI2019-9056458.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e65/6444267/c398beb11b4f/BMRI2019-9056458.009.jpg

相似文献

1
Potential Role of lncRNA H19 as a Cancer Biomarker in Human Cancers Detection and Diagnosis: A Pooled Analysis Based on 1585 Subjects.长链非编码RNA H19作为癌症生物标志物在人类癌症检测与诊断中的潜在作用:基于1585名受试者的汇总分析
Biomed Res Int. 2019 Mar 19;2019:9056458. doi: 10.1155/2019/9056458. eCollection 2019.
2
Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis.长链非编码 RNA 和环状 RNA 作为炎症性肠病潜在诊断生物标志物的系统评价和荟萃分析。
Front Immunol. 2024 Mar 8;15:1362437. doi: 10.3389/fimmu.2024.1362437. eCollection 2024.
3
Long noncoding RNA MALAT1 acts as a potential biomarker in cancer diagnosis and detection: a meta-analysis.长链非编码 RNA MALAT1 作为一种潜在的癌症诊断和检测生物标志物的荟萃分析。
Biomark Med. 2019 Jan;13(1):45-54. doi: 10.2217/bmm-2018-0128. Epub 2018 Dec 18.
4
Long Non-Coding RNA MALAT1 as a Detection and Diagnostic Molecular Marker in Various Human Cancers: A Pooled Analysis Based on 3255 Subjects.长链非编码RNA MALAT1作为多种人类癌症的检测和诊断分子标志物:基于3255名受试者的汇总分析
Onco Targets Ther. 2020 Jun 19;13:5807-5817. doi: 10.2147/OTT.S250796. eCollection 2020.
5
Diagnostic value of HOX transcript antisense RNA for cancer detection: a meta-analysis.HOX 转录反义 RNA 用于癌症检测的诊断价值:一项荟萃分析。
Biomark Med. 2020 Apr;14(5):401-411. doi: 10.2217/bmm-2019-0207. Epub 2020 Apr 9.
6
The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.外泌体来源的长非编码 RNA 在癌症患者中的诊断和预后价值:一项荟萃分析。
Clin Exp Med. 2020 Aug;20(3):339-348. doi: 10.1007/s10238-020-00638-z. Epub 2020 Jun 5.
7
Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.检测微小RNA-21表达作为结直肠癌潜在筛查生物标志物的Meta分析
Asian Pac J Cancer Prev. 2014;15(18):7583-8. doi: 10.7314/apjcp.2014.15.18.7583.
8
Long Non-Coding RNA HOTAIR as Ideal Biomarker for the Diagnosis of Various Carcinomas.长链非编码RNA HOTAIR作为多种癌症诊断的理想生物标志物
Clin Lab. 2019 Dec 1;65(12). doi: 10.7754/Clin.Lab.2019.190406.
9
Long non-coding RNA as potential diagnostic markers for acute myeloid leukemia: A systematic review and meta-analysis.长非编码 RNA 作为急性髓系白血病潜在诊断标志物的系统评价和荟萃分析。
Cancer Med. 2024 Jun;13(11):e7376. doi: 10.1002/cam4.7376.
10
Long noncoding RNA MALAT1 as a candidate serological biomarker for the diagnosis of non-small cell lung cancer: A meta-analysis.长链非编码 RNA MALAT1 作为非小细胞肺癌血清学诊断标志物的候选物:一项荟萃分析。
Thorac Cancer. 2020 Feb;11(2):329-335. doi: 10.1111/1759-7714.13265. Epub 2019 Dec 17.

引用本文的文献

1
Prognostic and clinicopathological significance of long noncoding RNA SNHG in patients with breast cancer: A systematic review and meta-analysis.长链非编码RNA SNHG在乳腺癌患者中的预后及临床病理意义:一项系统评价和荟萃分析
Medicine (Baltimore). 2025 Feb 21;104(8):e41668. doi: 10.1097/MD.0000000000041668.
2
Ropivacaine suppresses the progression of renal cell carcinoma through regulating the lncRNA RMRP/EZH2/CCDC65 axis.罗哌卡因通过调控 lncRNA RMRP/EZH2/CCDC65 轴抑制肾细胞癌的进展。
Daru. 2024 Jun;32(1):121-132. doi: 10.1007/s40199-023-00492-w. Epub 2023 Nov 27.
3
Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases.

本文引用的文献

1
Prognostic and clinicopathological role of long non-coding RNA taurine upregulated 1 in various human malignancies: A systemic review and meta-analysis.长链非编码RNA牛磺酸上调基因1在多种人类恶性肿瘤中的预后及临床病理作用:一项系统评价和荟萃分析
Tumour Biol. 2017 Jul;39(7):1010428317714361. doi: 10.1177/1010428317714361.
2
Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.长链非编码RNA H19和微小RNA let7a表达对甲状腺癌预后的影响。
Exp Mol Pathol. 2017 Aug;103(1):71-77. doi: 10.1016/j.yexmp.2017.06.004. Epub 2017 Jun 24.
3
Prognostic and clinicopathological significance of CCAT2 in Chinese patients with various tumors.
靶向非编码RNA H19:肺部疾病的一种潜在治疗方法。
Front Pharmacol. 2022 Sep 16;13:978151. doi: 10.3389/fphar.2022.978151. eCollection 2022.
4
Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma.长链非编码RNA作为胆管癌的分子生物标志物
Front Cell Dev Biol. 2022 Apr 27;10:890605. doi: 10.3389/fcell.2022.890605. eCollection 2022.
5
Crosslinker-modified nucleic acid probes for improved target identification and biomarker detection.用于改善靶标识别和生物标志物检测的交联剂修饰核酸探针。
RSC Chem Biol. 2021 Feb 22;2(2):410-422. doi: 10.1039/d0cb00236d. eCollection 2021 Apr 1.
6
LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.长链非编码 RNA-DUXAP8 通过调控 Wnt/β-连环蛋白信号通路抑制急性髓系白血病中的糖酵解并诱导细胞凋亡。
Turk J Haematol. 2021 Dec 7;38(4):264-272. doi: 10.4274/tjh.galenos.2021.2020.0769. Epub 2021 Aug 25.
7
New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer.环状RNA在人类癌症中的新分子机制及临床影响
Cancers (Basel). 2021 Jun 24;13(13):3154. doi: 10.3390/cancers13133154.
8
Mitochondrial Dysfunction and Chronic Inflammation in Polycystic Ovary Syndrome.多囊卵巢综合征中的线粒体功能障碍与慢性炎症。
Int J Mol Sci. 2021 Apr 10;22(8):3923. doi: 10.3390/ijms22083923.
9
Increased level of long non coding RNA H19 is correlated with the downregulation of miR-326 and BCL-2 genes in pediatric acute lymphoblastic leukemia, a possible hallmark for leukemogenesis.长链非编码 RNA H19 水平升高与小儿急性淋巴细胞白血病中 miR-326 和 BCL-2 基因下调相关,这可能是白血病发生的一个标志。
Mol Biol Rep. 2021 Feb;48(2):1531-1538. doi: 10.1007/s11033-021-06161-y. Epub 2021 Feb 12.
10
Icariin attenuates endothelial-mesenchymal transition via H19/miR-148b-3p/ELF5 in ox-LDL-stimulated HUVECs.淫羊藿苷通过H19/miR-148b-3p/ELF5途径减轻氧化型低密度脂蛋白刺激的人脐静脉内皮细胞的内皮-间充质转化。
Mol Ther Nucleic Acids. 2020 Dec 3;23:464-475. doi: 10.1016/j.omtn.2020.11.021. eCollection 2021 Mar 5.
CCAT2在中国各类肿瘤患者中的预后及临床病理意义。
Int J Biol Markers. 2017 Jul 24;32(3):e344-e351. doi: 10.5301/ijbm.5000281.
4
Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas.长链非编码RNA UCA1在各种癌症中的预后及临床病理作用
Oncotarget. 2017 Apr 25;8(17):28373-28384. doi: 10.18632/oncotarget.16059.
5
Prognostic role of the long non-coding RNA, SPRY4 Intronic Transcript 1, in patients with cancer: a meta-analysis.长链非编码RNA SPRY4内含子转录本1在癌症患者中的预后作用:一项荟萃分析
Oncotarget. 2017 May 16;8(20):33713-33724. doi: 10.18632/oncotarget.16735.
6
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
7
Clinical outcomes in patients treated with radiotherapy after surgery for cervical cancer.宫颈癌手术后接受放射治疗患者的临床结局。
Radiat Oncol J. 2017 Mar;35(1):39-47. doi: 10.3857/roj.2016.01893. Epub 2016 Dec 12.
8
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.血浆中循环lncRNA H19作为乳腺癌的一种新型生物标志物。
Cancer Biomark. 2016 Jun 24;17(2):187-94. doi: 10.3233/CBM-160630.
9
Evaluation of the Role of Circulating Long Non-Coding RNA H19 as a Promising Novel Biomarker in Plasma of Patients with Gastric Cancer.循环长链非编码RNA H19作为胃癌患者血浆中有前景的新型生物标志物的作用评估
J Clin Lab Anal. 2016 Nov;30(6):1100-1105. doi: 10.1002/jcla.21987. Epub 2016 May 17.
10
A long non-coding RNA, APOA4-AS, regulates APOA4 expression depending on HuR in mice.一种长链非编码RNA,APOA4-AS,在小鼠中依赖HuR调节APOA4的表达。
Nucleic Acids Res. 2016 Jul 27;44(13):6423-33. doi: 10.1093/nar/gkw341. Epub 2016 Apr 29.